Director, Adcetris HCP and Lifecycle Strategy Lead

ROLE SUMMARY

At Pfizer, our vision is a world where people with cancer live better and longer lives. Together with the Hematology-Oncology community, we are dedicated to making meaningful change for people living with blood cancers.

Pfizer has over a decade of experience in Hematology-Oncology, with nine approved medicines available in over 80 countries in 18 indications that have reached over 239,000 patients worldwide. Our medicines treat the main types of blood cancers, including MM, chronic and acute leukemias, and lymphomas, spanning all three of our core scientific modalities: antibody-drug conjugates (ADCs), bispecific antibodies, and small molecules.

Our long-standing relationships with the blood cancer community are imperative to our work. We partner with organizations around the world to better understand and support the unique needs of patients living with blood cancers. Our collaborations with patients shape our work and enable us to optimize acc...